Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service

Scientific Journal Selector



CELLULAR ONCOLOGY


👁  36889 Views

 71 Reviews  

 Open Access      SCIE      Official Website     Submission Website
Return to Search
 

*Average Peer Review
Average 12 Month(s)
*Competitiveness
About 25%
CiteScore
10.3

CiteScore Rank
Subject Area Rank Percentile
Category: Medicine
Subcategory: Oncology
56 / 404
86%
Category: Medicine
Subcategory: Molecular Medicine
32 / 178
82%
Category: Medicine
Subcategory: Cancer Research
48 / 230
79%



Country/Area of Publication
NETHERLANDS
Publication Frequency
6 issues per year
Publisher
Springer Netherlands

ISSN
2211-3428
E-ISSN
2211-3436
Year Publication Started
2011

Self-citation (2023-2024)
2.00%
Annual Article Volume
136
Gold OA Percentage
29.94%


Open Access Info
APC APC Waiver Other Charges
N/A N/A N/A

Journal Aim & Scope
The Official Journal of the International Society for Cellular Oncology
Focuses on translational research
Addresses the conversion of cell biology to clinical applications
Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.
In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.


Web of Science Quartiles
WOS Quartile: Q1

Quartiles By JIFCollectionQuartileRankPercentage
Category: CELL BIOLOGYSCIEQ267/205
67.6%
Category: ONCOLOGYSCIEQ168/322
79%
Category: PATHOLOGYSCIEQ111/88
88.1%
Quartiles By JCICollectionQuartileRankPercentage
Category: CELL BIOLOGYSCIEQ144/205
78.78%
Category: ONCOLOGYSCIEQ163/322
80.59%
Category: PATHOLOGYSCIEQ116/88
82.39%
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    Journal of Extracellular Vesicles027.30
    AGING CELL11314.40
    Science Signaling1289.50
    Cell Death Discovery08.30
    Stem Cell Reports5510.50
    Frontiers in Cell and Developmental Biology09.70
    Stem Cell Reviews and Reports619.30
    Cell Regeneration05.80
    Cell Adhesion & Migration06.40
    Analytical Cellular Pathology184.90
  • CELLULAR ONCOLOGY CELLULAR ONCOLOGY
    Predict CiteScore Trend:
    Steady Increase No Change Gradual Decline  Refresh
 
    👁  36889 Views
      71 Reviews        
 
 
 

Select your rating and start your review of CELLULAR ONCOLOGY

 

    北陆安平
    Status: N/A

    2023-10-31

    Submitted in early April, accepted at the end of October, with 2 months of experiments in between




    北陆安平
    Status: N/A

    2023-10-31

    It's pretty fast for you. It took around 7 months for me to get accepted




    北马美美
    Status: N/A

    2023-10-29

    What's your problem?




    北马美美
    Status: N/A

    2023-10-29

    Wow, it's been such a long time?




    Phoebe
    Status: N/A

    2023-10-09

    Have you heard any news? Another magazine asked me to switch to them, I'm afraid




    无影白曼
    Status: N/A

    2023-08-13

    Research focus: Tumors; experience sharing: After a previous journal rejection, the publisher recommended this journal. I found out that earlier this year they had accepted a review article similar to ours on another type of cancer. But unfortunately, our submission was rejected without any reason




    混元新曦
    Status: N/A

    2023-07-18

    Don't you have invited reviewers? It will be like this, waiting all the time




    Alger Croft
    Status: N/A

    2023-06-26

    Has anyone applied recently? It's been six months and still under review




    Alger Croft
    Status: N/A

    2023-06-26

    You are really fast. I submitted my application one month after you did, and it's still under review




    Alger Croft
    Status: N/A

    2023-06-24

    Heavy research emphasis: tumor experience sharing: has anyone submitted recently? It's been under review for 5 months. Oh my god




Journals In The Same Field
CA-A CANCER JOURNAL FOR CLINICIANS
CiteScore: 873.20

LANCET
CiteScore: 148.10

NEW ENGLAND JOURNAL OF MEDICINE
CiteScore: 145.40

NATURE REVIEWS DRUG DISCOVERY
CiteScore: 137.40

NATURE REVIEWS CANCER
CiteScore: 111.90

NATURE MEDICINE
CiteScore: 100.90

Nature Reviews Clinical Oncology
CiteScore: 99.40

NATURE REVIEWS IMMUNOLOGY
CiteScore: 93.40

Lancet Respiratory Medicine
CiteScore: 87.10

Nature Reviews Disease Primers
CiteScore: 76.70



© 2010-2025  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
PrivacyTerms of Servic